Slide 1 Presented By Susan Chang at 2014 ASCO Annual Meeting.
Validation of RANO Criteria: Contribution of T2/FLAIR Assessment in Patients with Recurrent Glioblastoma Treated with Bevacizumab Presented By Raymond.
